Divi's Laboratories Ltd.

NSE: DIVISLAB | BSE: 532488 | ISIN: INE361B01024 | Industry: Pharmaceuticals
| Expensive Performer
6612.5000 -25.50 (-0.38%)
NSE Jun 15, 2026 15:03 PM
Volume: 156.7K
 

6612.50
-0.38%
Deven Choksey
We expect the company to grow its Revenue/EBITDA/PAT at a CAGR of 15.3% / 20% / 18.2% for the period of FY26-FY28.
Number of FII/FPI investors decreased from 868 to 842 in Mar 2026 qtr
More from Divi's Laboratories Ltd.
Recommended